News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
223,172 Results
Type
Article (14084)
Company Profile (91)
Press Release (208997)
Section
Business (62901)
Career Advice (389)
Deals (11711)
Drug Delivery (28)
Drug Development (43999)
Employer Resources (21)
FDA (4846)
Job Trends (4802)
News (119364)
Policy (8642)
Tag
Academia (883)
Alliances (18588)
Alzheimer's disease (891)
Antibody-drug conjugate (ADC) (89)
Approvals (4820)
Artificial intelligence (92)
Bankruptcy (71)
Best Places to Work (4412)
Biotechnology (83)
Breast cancer (143)
Cancer (1129)
Cardiovascular disease (69)
Career advice (307)
CAR-T (83)
Cell therapy (222)
Clinical research (34981)
Collaboration (366)
Compensation (120)
COVID-19 (944)
C-suite (72)
Data (1041)
Diabetes (92)
Diagnostics (2017)
Drug discovery (63)
Earnings (26098)
Events (36262)
Executive appointments (206)
FDA (5249)
Funding (282)
Gene editing (62)
Gene therapy (123)
GLP-1 (304)
Government (1130)
Healthcare (6155)
Infectious disease (996)
Inflammatory bowel disease (94)
IPO (6465)
Job creations (651)
Job search strategy (246)
Layoffs (130)
Legal (991)
Lung cancer (181)
Lymphoma (78)
Manufacturing (76)
Medical device (2492)
Medtech (2494)
Mergers & acquisitions (5455)
Metabolic disorders (249)
Neuroscience (1115)
NextGen: Class of 2025 (1679)
Non-profit (879)
Northern California (1108)
Obesity (135)
Opinion (78)
Parkinson's disease (70)
Patents (78)
People (15664)
Phase I (13033)
Phase II (15982)
Phase III (10081)
Pipeline (478)
Postmarket research (656)
Preclinical (5363)
Radiopharmaceuticals (199)
Rare diseases (182)
Real estate (959)
Regulatory (7244)
Research institute (960)
Resumes & cover letters (117)
Series A (62)
Southern California (995)
Startups (1453)
United States (8392)
Vaccines (244)
Weight loss (74)
Date
Today (19)
Last 7 days (347)
Last 30 days (1068)
Last 365 days (18640)
2025 (846)
2024 (18784)
2023 (20428)
2022 (24745)
2021 (24183)
2020 (20420)
2019 (14512)
2018 (10667)
2017 (11690)
2016 (9938)
2015 (11922)
2014 (7881)
2013 (5999)
2012 (6115)
2011 (6287)
2010 (5499)
Location
Africa (163)
Asia (14902)
Australia (2856)
California (2464)
Canada (728)
China (234)
Colorado (103)
Connecticut (128)
Europe (34492)
Florida (296)
Illinois (137)
Indiana (102)
Japan (76)
Maryland (289)
Massachusetts (1917)
Minnesota (103)
New Jersey (574)
New York (643)
North Carolina (292)
Northern California (1108)
Pennsylvania (472)
South America (219)
Southern California (995)
Texas (322)
Washington State (277)
223,172 Results for "target pharmasolutions".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Mikart and Nano PharmaSolutions complete key milestones
Mikart, LLC, a leading contract development and manufacturing organization, is thrilled to announce a significant milestone in its collaboration with Nano PharmaSolutions, Inc..
May 7, 2024
·
2 min read
Approvals
Astellas’ First-in-Class, Claudin-Targeted Therapy Wins FDA Nod for Certain Gastric Cancers
The regulator’s approval on Friday of Vyloy for gastric or gastroesophageal junction cancer makes it the first and only claudin 18.2–targeted therapy approved in the U.S. for these indications, according to Astellas.
October 21, 2024
·
2 min read
·
Tristan Manalac
CRISPR
CRISPR
Ex Vivo
Gene Editing Gets on Target With Caribou’s Hybrid Guides
While
ex vivo
genome editing results in highly effective cell therapies, it can lead to off-target effects. Caribou Biosciences has come up with a novel approach for potentially more precise gene editing compared to all-RNA guides.
October 14, 2024
·
5 min read
·
Greg Slabodkin
Press Releases
Highlander Health Announces Inaugural Investment of Target RWE
January 7, 2025
·
2 min read
Press Releases
Immuron Announces New Research Collaboration targeting Antimicrobial Resistance
January 15, 2025
·
10 min read
Mergers & acquisitions
GSK Targets Rare Cancer With $1B+ Acquisition of IDRx
The first major deal of JPM 2025 will give GSK a promising small molecule drug for gastrointestinal stromal tumors.
January 13, 2025
·
2 min read
·
Tristan Manalac
Press Releases
etherna Announces Strategic Multi-Target Collaboration with Dropshot Therapeutics
January 9, 2025
·
2 min read
Press Releases
Imdelltra Tarlatamab Commercial Success To Drive DLL3 Targeted Therapy Market
January 15, 2025
·
1 min read
Press Releases
Simnova and Orna Expand Strategic Partnership to Include BCMA-Targeted RNA Therapeutics
January 15, 2025
·
2 min read
Press Releases
Rancho Biosciences and ONTOFORCE Collaborate to Leverage High Quality Data for Target Identification
January 15, 2025
·
3 min read
1 of 22,318
Next
